绝经状态影响饮茶与乳腺癌患病风险关系的meta分析

doi:10.3969/j.issn.1004-616x.2018.05.013

Abstract

Abstract: OBJECTIVE:To ascertain the potential relationship between tea consumption and risk of premenopausal and post-menopausal breast cancer. METHODS:Web of Science,PubMed,Medline,CNKI,VIP and WanFang database were independently searched from January 1st, 1996 to August 31st, 2017 by using "tea OR catechin OR tea polyphenol" AND "breast OR mammary" AND "cancer OR tumor OR carcinoma" as key words. The combination of the effect values and the heterogeneity test were performed using Stata 11.0 software. Each study was scored using the NOS (New Castle Ottawa Scale),and the publication bias was calculated using the funnel and Egger regression. RESULTS:A total of 9 studies (5 case-control studies;4 cohort studies) were included. The studies showed that tea intake was insignificantly associated with risk of breast cancer (OR=1.01,95% CI:0.86-1.18),the highest tea intake was also insignificant for risk of premenopausal (OR=0.92,95% CI:0.82-1.04) and postmenopausal breast cancers (OR=1.11,95% CI:0.93-1.33). In addition, we did not identify any statistically significant association between tea consumption and breast cancer risk in all the subgroup analyses (P < 0.05). CONCLUSION:In conclusion,our findings indicate that menopausal status had no effect on tea consumption and breast cancer risk. But the current evidence is still relatively limited. Therefore, large sample,multi-center cohort or case-control studies should be conducted to further clarify the accuracy of this conclusion.

Key words: tea, breast cancer, menopause, meta-analysis

CLC Number:

R151.3

XIAO Hongmei, PAN Tianqi, DONG Shunan, FU Lingmeng, WANG Shaokang, SUN Guiju. Menopausal status on risk for breast cancer from tea consumption: a meta-analysis[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2018, 30(5): 395-399.

References

[1] TORRE L A,BRAY F,SIEGEL R L,et al. Global cancer statistics,2012[J]. Ca A Cancer J Clin,2015,65(2):87-108.
[2] 师金,梁迪,李道娟,等. 全球女性乳腺癌流行情况研究[J]. 中国肿瘤,2017,26(9):683-690.
[3] CHEN W Q, ZHENG R S, BAADE P D, et al. Cancer statistics in China, 2015[J]. Ca A Cancer J Clin, 2016, 66(2):115-132.
[4] GRAHAM H N. Green tea composition, consumption, and polyphenol chemistry[J]. Prev Med,1992,21(3):334-350.
[5] HAYAT K, IQBAL H, MALIK U, et al. Tea and its consumption:benefits and risks[J]. Crit Rev Food Sci,2015, 55(7):939-954.
[6] FUJIKI H,SUEOKA E,WATANABE T,et al. Synergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG,other green tea catechins,and anticancer compounds[J]. J Cancer Res Clin, 2015,141(9):1511-1522.
[7] BONOFIGLIO D, GIORDANO C, DE AMICIS F, et al. Natural products as promising antitumoral agents in breast cancer:mechanisms of action and molecular targets[J]. Mini-Rev Med Chem,2016,16(8):596-604.
[8] CHEN Z H, YU T, ZHOU B F, et al. Mg(Ⅱ)-Catechin nanoparticles delivering siRNA targeting EIF5A2 inhibit bladder cancer cell growth in vitro and in vivo[J]. Biomaterials,2016, 81(1):125-134.
[9] OGUNLEYE A A, XUE F, MICHELS K B. Green tea consumption and breast cancer risk or recurrence:a meta-analysis[J]. Breast Cancer Res Treat,2010,119(2):477-484.
[10] ZHANG Y F,XU Q,LU J,et al. Tea consumption and the incidence of cancer:a systematic review and meta-analysis of prospective observational studies[J]. Eur J Cancer Prev,2015, 24(4):353-362.
[11] YU F F,JIN Z C,JIANG H,et al. Tea consumption and the risk of five major cancers:a dose-response meta-analysis of prospective studies[J]. BMC Cancer,2014,14:197.
[12] SUN C L,YUAN J M,KOH W P,et al. Green tea,black tea and breast cancer risk:a meta-analysis of epidemiological studies[J]. Carcinogenesis,2006,27(7):1310-1315.
[13] GAO Y,HUANG Y B,LIU X O,et al. Tea consumption, alcohol drinking and physical activity associations with breast cancer risk among Chinese females:a systematic review and meta-analysis[J]. Asian Pac J Cancer P,2013,14(12):7543-7550.
[14] OH J K,SANDIN S,STROM P,et al. Prospective study of breast cancer in relation to coffee,tea and caffeine in Sweden[J]. Internat J Cancer,2015,137(8):1979-1989.
[15] BHOO-PATHY N,PEETERS P H,UITERWAAL C S,et al. Coffee and tea consumption and risk of pre-and postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study[J]. Breast Cancer Res,2015,17(1):1-12.
[16] DAI Q, SHU X O, LI H L, et al. Is green tea drinking associated with a later onset of breast cancer?[J]. Ann Epidemiol,2010,20(1):74-81.
[17] BOGGS D A,PALMER J R,STAMPFER M J,et al. Tea and coffee intake in relation to risk of breast cancer in the black women's health study[J]. Cancer Causes Control, 2010, 21(11):1941-1948.
[18] LI M, TSE L A, CHAN W C, et al. Evaluation of breast cancer risk associated with tea consumption by menopausal and estrogen receptor status among Chinese women in Hong Kong[J]. Cancer Epidemiol,2016,40(1):73-78.
[19] 李彬,汪莲,莫雄飞,等.饮茶与女性乳腺癌易感性的病例对照研究[J]. 华南预防医学,2014,40(3):201-207.
[20] IWASAKI M,MIZUSAWA J,KASUGA Y,et al. Green tea consumption and breast cancer risk in japanese women:a case-control study[J]. Nutr Cancer,2014,66(1):57-67.
[21] SHRUBSOLE M J,LU W,CHEN Z,et al. Drinking green tea modestly reduces breast cancer risk[J]. J Nutrit, 2009, 139(2):310-316.
[22] 陶梦华,刘大可,高立峰,等. 饮茶与女性乳腺癌的关系[J]. 肿瘤,2002,22(3):176-180.
[23] 任国峰,杨俊峰. 绿茶摄入对乳腺癌发病风险影响的Meta分析[J]. 食品科学,2013,34(3):276-279.
[24] 郑佳,徐婷,葛霞英,等. 茶摄入与乳腺癌发病风险关系的系统评价Meta分析[J]. 疾病监测,2017,32(7):597-602.
[25] 吴文华. 普洱茶调节血脂功能评价及其生化机理的研究[D]. 重庆:西南农业大学,2003

Menopausal status on risk for breast cancer from tea consumption: a meta-analysis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	XIN Yumeng, LIANG Huanxi, YU Yuehua, SUN Zhenxiao. Network pharmacology and molecular docking mechanisms of licorice and dried ginger decoction against breast cancers [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2022, 34(1): 7-13.
[2]	ZHAO Yan, SUN Zhenxiao. Metformin inhibitd proliferation and migration of human breast cancer cell in vitro [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2022, 34(1): 35-39.
[3]	FANG Yutong, ZHANG Qunchen, HONG Chaoqun, CHEN Chunfa, CHEN Jiongyu, ZHANG Rendong, WU Jundong. Mechanisms of miR-221 and miR-222 on expression of GATA3 and FOXA1 and their effects in breast cancer [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(6): 435-441,460.
[4]	ZHANG Shimin, ZHAO Ruijun. Expression of protein tyrosine phosphatase receptor J in breast cancer tissues and its relationship with clinical prognosis [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(4): 276-279,285.
[5]	CHENG Bin, WANG Xinyu, SUN Yu, ZHANG Jiatai, DONG Shuying. Inhibition of metformin on phthalate-induced proliferation and migration of MCF-7 breast cancer cells [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(3): 197-202.
[6]	LUO Jiao, ZHANG Kunchi, ZHOU Li. Analysis of differentially expressed microRNAs between the triple negative breast cancer cell line MDA-MB-231 and its brain metastasis cell line [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(3): 218-224.
[7]	LI Weiwei, ZHU Ying. Data mining analyses of expression and prognostic values of the MYB family in breast cancer [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(6): 414-422.
[8]	CHEN Mianling, MA Shuoyi. Regulation of migration and invasion of triple-negative breast cancer cell MDA-MB-231 by miR-21 via targeting PDCD4 [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(4): 292-297.
[9]	ZHANG Huijuan, HUANG Dayuan, ZHANG Jie, TANG Haiou, XIE Anxin, TAN Dunyong. Effects of SF1a-PRLR and ΔS2 SF1a-PRLR on proliferation and microRNA expressionin MCF-7 breast cancer cell [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(3): 203-208.
[10]	SUN Quanwu, DU Xiaoping, HAO Jie, SHI Rong, LIU Bo, HUANG Haiyun. β1 integrin expression in breast cancer patients with pathological nipple discharge [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2019, 31(5): 368-372.
[11]	WANG Lan, ZHANG Yongdong, GUO Hongyun, WANG Tao, WANG Haitao, GUO Huan, YANG Suisheng, LI Xiaoqin, SU Haixiang. Relationships between XRCC3 polymorphisms and breast cancer in northern Chinese women [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2019, 31(5): 392-396,400.
[12]	YANG Jinru, QIN Lulu, ZHU Yongfei. Meta analysis on association between JAK2 gene mutation and susceptibility to chronic myeloid leukemia [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2019, 31(3): 231-237.
[13]	WU Wen, LI Ping, ZUO Ran, ZENG Qingbo, WU Desheng, XIE Ni, LONG Dingxin, YUAN Jianhui. Correlation between polymorphism of DNA methyltransferase 3B-149C>T and cancer risk:a meta-analysis [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2019, 31(2): 102-110.
[14]	DU Juan, HU Xiangyang, LIU Dan, HU Wei, CHEN Tao. Inhibitory effect of total alkaloids of Tougucao on bone metastasis of breast cancer cells in mice [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2018, 30(6): 435-441.
[15]	XU Shizhang, XIE Minjuan. Relation between ACE gene polymorphism and pediatric idiopathic steroid-sensitive nephrotic syndrome: a meta-analysis [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2018, 30(6): 447-451.